Source: Journal of Controlled Release. Unidade: FM
Subjects: DNA, GENÉTICA (TERAPIA), NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Adriana L. da et al. DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma. Journal of Controlled Release, v. 180, n. 1, p. 125-133, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2014.02.010. Acesso em: 05 nov. 2024.APA
Silva, A. L. da, Martini, S. V., Abreu, S. C., Samary, C. dos S., Diaz, B. L., Fernezlian, S., et al. (2014). DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma. Journal of Controlled Release, 180( 1), 125-133. doi:10.1016/j.jconrel.2014.02.010NLM
Silva AL da, Martini SV, Abreu SC, Samary C dos S, Diaz BL, Fernezlian S, Sá VK de, Capelozzi VL, Boylan NJ, Goya RG, Suk JS, Rocco PRM, Hanes J, Morales MM. DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma [Internet]. Journal of Controlled Release. 2014 ; 180( 1): 125-133.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2014.02.010Vancouver
Silva AL da, Martini SV, Abreu SC, Samary C dos S, Diaz BL, Fernezlian S, Sá VK de, Capelozzi VL, Boylan NJ, Goya RG, Suk JS, Rocco PRM, Hanes J, Morales MM. DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma [Internet]. Journal of Controlled Release. 2014 ; 180( 1): 125-133.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jconrel.2014.02.010
